Rx: 3x/week LAAM: alternative to methadone. Clinical studies: Phase I.
D000700:Analgesics; D000701:Analgesics, Opioid; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D004361:Drug Tolerance; D003932:Heroin / Q000037:antagonists & inhibitors; D006556:Heroin Dependence / Q000534:rehabilitation; D006801:Humans; D007700:Kinetics; D008691:Methadone / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D008692:Methadyl Acetate / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D009020:Morphine / Q000037:antagonists & inhibitors; D009021:Morphine Dependence / Q000503:physiopathology; D010352:Patient Dropouts; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy; D013997:Time Factors
D000700:Analgesics; D000701:Analgesics, Opioid; D003932:Heroin; D009020:Morphine; D008692:Methadyl Acetate; D008691:Methadone